Related references
Note: Only part of the references are listed.Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics
Jean-Laurent Casanova et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors
Zuzana Jedlickova et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
Alan M. Hanash et al.
BLOOD (2011)
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system
Thomas Luft et al.
BLOOD (2011)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E. D. Flowers et al.
BLOOD (2011)
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
Ho-Jin Shin et al.
BLOOD (2011)
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial
Evelien Kneppers et al.
BLOOD (2011)
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism
Dennis B. Leveson-Gower et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients
R. Crocchiolo et al.
EXPERIMENTAL HEMATOLOGY (2011)
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
Suzanne van Dorp et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells
Eleonora Tresoldi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity
Dipica Haribhai et al.
IMMUNITY (2011)
Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice
Huihui Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Danger signals activating innate immunity in graft-versus-host disease
Robert Zeiser et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Th17/Treg ratio in human graft-versus-host disease
Philippe Ratajczak et al.
BLOOD (2010)
Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells
J. M. Palmer et al.
BONE MARROW TRANSPLANTATION (2010)
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
D. Hoda et al.
BONE MARROW TRANSPLANTATION (2010)
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
J. Y. Weng et al.
BONE MARROW TRANSPLANTATION (2010)
MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease
Markus M. Heimesaat et al.
GUT (2010)
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
Claudio Procaccini et al.
IMMUNITY (2010)
Endogenous toll-like receptor ligands and their biological significance
Li Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor Growth
Olaf Penack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Konrad Wilhelm et al.
NATURE MEDICINE (2010)
Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells
Jakub Tolar et al.
STEM CELLS (2010)
Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Graft-versus-Host disease Prophylaxis with Everolimus and Tacrolimus Is Associated with a High Incidence of Sinusoidal Obstruction Syndrome and Microangiopathy: Results of the EVTAC Trial
Uwe Platzbecker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
John Koreth et al.
BLOOD (2009)
IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation
Christoph Bucher et al.
BLOOD (2009)
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
Asha B. Pillai et al.
BLOOD (2009)
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
Leonardo Magro et al.
BLOOD (2009)
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Attilio Olivieri et al.
BLOOD (2009)
Rituximab reduces the incidence of acute graft-versus-host disease
Maximilian Christopeit et al.
BLOOD (2009)
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
Tangsheng Yi et al.
BLOOD (2009)
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2009)
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study
M. Schleuning et al.
BONE MARROW TRANSPLANTATION (2009)
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M. von Bonin et al.
BONE MARROW TRANSPLANTATION (2009)
PKC inhibitors: potential in T cell-dependent immune diseases
Gottfried Baier et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning
Karin Landfried et al.
CURRENT OPINION IN ONCOLOGY (2009)
PKC theta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice
Javier O. Valenzuela et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
NOD2 regulates hematopoietic cell function during graft-versus-host disease
Olaf Penack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
Anna Maria Wolf et al.
JOURNAL OF IMMUNOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
What's next in the pipeline
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Elevated numbers of immature/transitional CD2I- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease
Hildegard T. Greinix et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Statins inhibit human APC function: implications for the treatment of GVHD
Alexander Shimabukuro-Vornhagen et al.
BLOOD (2008)
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation
Mehdi Hamadani et al.
BLOOD (2008)
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
Corey Cutler et al.
BLOOD (2008)
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Helen Karlsson et al.
BLOOD (2008)
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection
Patricia A. Taylor et al.
BLOOD (2008)
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD
L. Magro et al.
BONE MARROW TRANSPLANTATION (2008)
Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling
J. Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis
Hans Skvara et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice
Pavan Reddy et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis
Tomohiro Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen
Nainong Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels
Ursula Schenk et al.
SCIENCE SIGNALING (2008)
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4(+)CD25(high)FOXP3(+) regulatory T cells
Zohair Selmani et al.
STEM CELLS (2008)
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs
Andreas Beilhack et al.
BLOOD (2008)
Finding a way out: lymphocyte egress from lymphoid organs
Susan R. Schwab et al.
NATURE IMMUNOLOGY (2007)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Pivotal Advance:: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
Maria Loiarro et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Treatment of refractory chronic GVHD with rituximab: a GITMO study
F. Zaja et al.
BONE MARROW TRANSPLANTATION (2007)
Vascular endothelial growth factor and activin-A serum levels following allogeneic hematopoietic stem cell transplantation
David Nachbaur et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Silvia Svegliati et al.
BLOOD (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation
Asha B. Pillai et al.
JOURNAL OF IMMUNOLOGY (2007)
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
Kyung-Hun Lee et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells
J. J. A. Coenen et al.
BONE MARROW TRANSPLANTATION (2007)
Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation
Juan Mateos-Mazon et al.
HAEMATOLOGICA (2007)
Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections
Sabine Mumprecht et al.
BLOOD (2006)
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Katayoun Rezvani et al.
BLOOD (2006)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation:: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination
E Holler et al.
BLOOD (2006)
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco et al.
BLOOD (2006)
Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
K Sun et al.
BLOOD (2005)
The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation
AM Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prospective monitoring of tumor necrosis factor α and interferon γ to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
D Ritchie et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
A Beilhack et al.
BLOOD (2005)
Host-residual invariant NK T cells attenuate graft-versus-host immunity
K Haraguchi et al.
JOURNAL OF IMMUNOLOGY (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
YR Lee et al.
BLOOD (2005)
Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-κB and Akt signaling pathways
S Appel et al.
CLINICAL CANCER RESEARCH (2005)
Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-10 processing
S Maeda et al.
SCIENCE (2005)
Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab
M Tokunaga et al.
RHEUMATOLOGY (2005)
Toward an understanding of NKT cell biology: Progress and paradoxes
M Kronenberg
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells
D Hashimoto et al.
JOURNAL OF IMMUNOLOGY (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Transplanted human bone marrow contributes to vascular endothelium
SG Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
K Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease
M Merad et al.
NATURE MEDICINE (2004)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT):: Requirement for GALT dendritic cells and adjuvant
B Johansson-Lindbom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
S Kulkarni et al.
BONE MARROW TRANSPLANTATION (2003)
Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells
SM Rigby et al.
BLOOD (2003)
Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720
YM Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Langerhans cells renew in the skin throughout life under steady-state conditions
M Merad et al.
NATURE IMMUNOLOGY (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease
BC Biedermann et al.
LANCET (2002)
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease
Y Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Non-hematopoietic allograft cells directly activate CD8(+) T cells and trigger acute rejection: An alternative mechanism of allorecognition
D Kreisel et al.
NATURE MEDICINE (2002)
Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation
J Cavet et al.
BLOOD (2001)
Predominance of NK1.1+TCRαβ+ or DX5+TCRαβ+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease:: Natural suppressor cells
FS Lan et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
A Limmer et al.
NATURE MEDICINE (2000)
Response to thalidomide therapy in refractory chronic graft-versus-host disease
PV Browne et al.
BONE MARROW TRANSPLANTATION (2000)
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells
A Mehling et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
